BRIP1
Fanconi anemia group J protein
Also known as: BACH1, FANCJ, FANCJ_HUMAN, OF
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BX63
- Gene
- BRIP1
- Ensembl
- ENSG00000136492
- Chromosome
- 17
- Canonical length
- 1249 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear membrane
OverviewNCBI Gene
The protein encoded by this gene is a member of the RecQ DEAH helicase family and interacts with the BRCT repeats of breast cancer, type 1 (BRCA1). The bound complex is important in the normal double-strand break repair function of breast cancer, type 1 (BRCA1). This gene may be a target of germline cancer-inducing mutations. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1249 residues, UniProt reviewed canonical sequence.
>Q9BX63|BRIP1
1 MSSMWSEYTI GGVKIYFPYK AYPSQLAMMN SILRGLNSKQ HCLLESPTGS GKSLALLCSA
61 LAWQQSLSGK PADEGVSEKA EVQLSCCCAC HSKDFTNNDM NQGTSRHFNY PSTPPSERNG
121 TSSTCQDSPE KTTLAAKLSA KKQASIYRDE NDDFQVEKKR IRPLETTQQI RKRHCFGTEV
181 HNLDAKVDSG KTVKLNSPLE KINSFSPQKP PGHCSRCCCS TKQGNSQESS NTIKKDHTGK
241 SKIPKIYFGT RTHKQIAQIT RELRRTAYSG VPMTILSSRD HTCVHPEVVG NFNRNEKCME
301 LLDGKNGKSC YFYHGVHKIS DQHTLQTFQG MCKAWDIEEL VSLGKKLKAC PYYTARELIQ
361 DADIIFCPYN YLLDAQIRES MDLNLKEQVV ILDEAHNIED CARESASYSV TEVQLRFARD
421 ELDSMVNNNI RKKDHEPLRA VCCSLINWLE ANAEYLVERD YESACKIWSG NEMLLTLHKM
481 GITTATFPIL QGHFSAVLQK EEKISPIYGK EEAREVPVIS ASTQIMLKGL FMVLDYLFRQ
541 NSRFADDYKI AIQQTYSWTN QIDISDKNGL LVLPKNKKRS RQKTAVHVLN FWCLNPAVAF
601 SDINGKVQTI VLTSGTLSPM KSFSSELGVT FTIQLEANHI IKNSQVWVGT IGSGPKGRNL
661 CATFQNTETF EFQDEVGALL LSVCQTVSQG ILCFLPSYKL LEKLKERWLS TGLWHNLELV
721 KTVIVEPQGG EKTNFDELLQ VYYDAIKYKG EKDGALLVAV CRGKVSEGLD FSDDNARAVI
781 TIGIPFPNVK DLQVELKRQY NDHHSKLRGL LPGRQWYEIQ AYRALNQALG RCIRHRNDWG
841 ALILVDDRFR NNPSRYISGL SKWVRQQIQH HSTFESALES LAEFSKKHQK VLNVSIKDRT
901 NIQDNESTLE VTSLKYSTSP YLLEAASHLS PENFVEDEAK ICVQELQCPK IITKNSPLPS
961 SIISRKEKND PVFLEEAGKA EKIVISRSTS PTFNKQTKRV SWSSFNSLGQ YFTGKIPKAT
1021 PELGSSENSA SSPPRFKTEK MESKTVLPFT DKCESSNLTV NTSFGSCPQS ETIISSLKID
1081 ATLTRKNHSE HPLCSEEALD PDIELSLVSE EDKQSTSNRD FETEAEDESI YFTPELYDPE
1141 DTDEEKNDLA ETDRGNRLAN NSDCILAKDL FEIRTIKEVD SAREVKAEDC IDTKLNGILH
1201 IEESKIDDID GNVKTTWINE LELGKTHEIE IKNFKPSPSK NKGMFPGFKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BRIP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 3.4 nTPM
Expression across tissuesHPA
Tissue
- thymus: 3.4 nTPM
- bone marrow: 2.6 nTPM
- tonsil: 1.8 nTPM
- testis: 1.3 nTPM
- lymph node: 0.9 nTPM
- colon: 0.7 nTPM
Single-cell type
- late spermatids: 296 nCPM
- erythrocyte progenitors: 195 nCPM
- neutrophil progenitors: 195 nCPM
- early spermatids: 194 nCPM
- megakaryocyte progenitors: 177 nCPM
- monocyte progenitors: 175 nCPM
Immune cell
- basophil: 1 nTPM
- T-reg: 0.8 nTPM
- memory B-cell: 0.2 nTPM
- memory CD4 T-cell: 0.2 nTPM
- naive B-cell: 0.2 nTPM
- naive CD4 T-cell: 0.2 nTPM
Brain region
- cerebellum: 6 nTPM
- white matter: 4.8 nTPM
- basal ganglia: 4.7 nTPM
- cerebral cortex: 4.7 nTPM
- amygdala: 4.4 nTPM
- hippocampal formation: 4.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BRIP1.
Disease | AllUniProt
Conditions BRIP1 is implicated in, by any mechanism.
- Breast cancer (BC) MIM:114480
- Fanconi anemia complementation group J (FANCJ) MIM:609054
Disease | GeneticClinVar
898 pathogenic / likely-pathogenic of 6,406 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Familial cancer of breast
- Fanconi anemia complementation group J
- Hereditary cancer-predisposing syndrome
- Ovarian cancer
- Familial ovarian cancer
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.79
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.2
- DepMap mean gene effect
- -0.33
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chiasma assembly
- DNA damage checkpoint signaling
- DNA repair
- double-strand break repair
- double-strand break repair involved in meiotic recombination
- homologous recombination
- meiotic DNA double-strand break processing involved in reciprocal meiotic recombination
- nucleotide-excision repair
- protein-DNA covalent cross-linking repair
- regulation of transcription by RNA polymerase II
- seminiferous tubule development
- spermatid development
- spermatogonial cell division
Molecular functions
- 4 iron, 4 sulfur cluster binding
- 5'-3' DNA helicase activity
- ATP binding
- ATP hydrolysis activity
- catalytic activity, acting on a nucleic acid
- DNA binding
- DNA helicase activity
- metal ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Helicase-like, DEXD box c2 type
- ATP-dependent helicase, C-terminal
- RAD3-like helicase, DEAD
- ATP-dependent helicase Rad3/Chl1-like
- Helicase superfamily 1/2, ATP-binding domain
- Helicase superfamily 1/2, ATP-binding domain, DinG/Rad3-type
- P-loop containing nucleoside triphosphate hydrolase
- Helicase superfamily 1/2, DinG/Rad3-like
- DEAD_2
- Helicase C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BRIP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BRIP1 as an antibody target. Whether an autoantibody or antibody against BRIP1 could matter depends on whether native BRIP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BRIP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BRIP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...